NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|2024351123|ref|XP_040502099|]
View 

thyrotropin releasing hormone isoform X1 [Gallus gallus]

Protein Classification

TRH domain-containing protein( domain architecture ID 10527181)

TRH domain-containing protein

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

 Name Accession Description Interval E-value
TRH pfam05438
Thyrotropin-releasing hormone (TRH); This family consists of several thyrotropin-releasing ...
 16-227 3.72e-101

Thyrotropin-releasing hormone (TRH); This family consists of several thyrotropin-releasing hormone (TRH) proteins. Thyrotropin-Releasing Hormone (TRH; pyroGlu-His-Pro-NH2), originally isolated as a hypothalamic neuropeptide hormone, most likely acts also as a neuromodulator and/or neurotransmitter in the central nervous system (CNS). This interpretation is supported by the identification of a peptidase localized on the surface of neuronal cells which has been termed TRH-degrading ectoenzyme (TRH-DE) since it selectively inactivates TRH. TRH has been used clinically for the treatment of spinocerebellar degeneration and disturbance of consciousness in humans.


:

Pssm-ID: 461653 [Multi-domain]  Cd Length: 220  Bit Score: 293.63  E-value: 3.72e-101
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024351123  16 SGVCLNGRQFPPELSENMGRSSLDDILQRSGSHMLQSVLKKVEKKEEMNKELNmPLPQWLSKRQHPGKRYISDPEKRQHP 95
Cdd:pfam05438  10 CNLTVNGGQSIPEEDEQDGRSPLDDILQRAESLLLRSILKKLQDEDGRNDGES-SQPEWLSKRQHPGKRYEEDLEKRQHP 88

                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024351123  96 GKRDVEEKASFGDIQKRQHLGKTEVEGyLVNYLELKKRQHPGRRSLWDQSTDISssqLTYLNELSKRQHPGRRYLMYKHQ 175
Cdd:pfam05438  89 GRREEEEEESYGDIQKRQHPGKREDEA-WDSYLELQKRQHPGRRSLLDQFSDNP---LGYLSELSKRQHPGRRYLMSKRQ 164

                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|....*.
gi 2024351123 176 HPSKRGWND---ELDLSD-QNWEKHQQFGNRDRDSDSPDYTGPCDLQQSAICNKDS 227
Cdd:pfam05438 165 HPGKRSWEDedeELDEEDlLELEKRQHPGKRFWDNSSPDLGSPCDVLDPASCSKTS 220
 
Name Accession Description Interval E-value
TRH pfam05438
Thyrotropin-releasing hormone (TRH); This family consists of several thyrotropin-releasing ...
 16-227 3.72e-101

Thyrotropin-releasing hormone (TRH); This family consists of several thyrotropin-releasing hormone (TRH) proteins. Thyrotropin-Releasing Hormone (TRH; pyroGlu-His-Pro-NH2), originally isolated as a hypothalamic neuropeptide hormone, most likely acts also as a neuromodulator and/or neurotransmitter in the central nervous system (CNS). This interpretation is supported by the identification of a peptidase localized on the surface of neuronal cells which has been termed TRH-degrading ectoenzyme (TRH-DE) since it selectively inactivates TRH. TRH has been used clinically for the treatment of spinocerebellar degeneration and disturbance of consciousness in humans.


Pssm-ID: 461653 [Multi-domain]  Cd Length: 220  Bit Score: 293.63  E-value: 3.72e-101
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024351123  16 SGVCLNGRQFPPELSENMGRSSLDDILQRSGSHMLQSVLKKVEKKEEMNKELNmPLPQWLSKRQHPGKRYISDPEKRQHP 95
Cdd:pfam05438  10 CNLTVNGGQSIPEEDEQDGRSPLDDILQRAESLLLRSILKKLQDEDGRNDGES-SQPEWLSKRQHPGKRYEEDLEKRQHP 88

                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024351123  96 GKRDVEEKASFGDIQKRQHLGKTEVEGyLVNYLELKKRQHPGRRSLWDQSTDISssqLTYLNELSKRQHPGRRYLMYKHQ 175
Cdd:pfam05438  89 GRREEEEEESYGDIQKRQHPGKREDEA-WDSYLELQKRQHPGRRSLLDQFSDNP---LGYLSELSKRQHPGRRYLMSKRQ 164

                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|....*.
gi 2024351123 176 HPSKRGWND---ELDLSD-QNWEKHQQFGNRDRDSDSPDYTGPCDLQQSAICNKDS 227
Cdd:pfam05438 165 HPGKRSWEDedeELDEEDlLELEKRQHPGKRFWDNSSPDLGSPCDVLDPASCSKTS 220
 
Name Accession Description Interval E-value
TRH pfam05438
Thyrotropin-releasing hormone (TRH); This family consists of several thyrotropin-releasing ...
 16-227 3.72e-101

Thyrotropin-releasing hormone (TRH); This family consists of several thyrotropin-releasing hormone (TRH) proteins. Thyrotropin-Releasing Hormone (TRH; pyroGlu-His-Pro-NH2), originally isolated as a hypothalamic neuropeptide hormone, most likely acts also as a neuromodulator and/or neurotransmitter in the central nervous system (CNS). This interpretation is supported by the identification of a peptidase localized on the surface of neuronal cells which has been termed TRH-degrading ectoenzyme (TRH-DE) since it selectively inactivates TRH. TRH has been used clinically for the treatment of spinocerebellar degeneration and disturbance of consciousness in humans.


Pssm-ID: 461653 [Multi-domain]  Cd Length: 220  Bit Score: 293.63  E-value: 3.72e-101
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024351123  16 SGVCLNGRQFPPELSENMGRSSLDDILQRSGSHMLQSVLKKVEKKEEMNKELNmPLPQWLSKRQHPGKRYISDPEKRQHP 95
Cdd:pfam05438  10 CNLTVNGGQSIPEEDEQDGRSPLDDILQRAESLLLRSILKKLQDEDGRNDGES-SQPEWLSKRQHPGKRYEEDLEKRQHP 88

                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024351123  96 GKRDVEEKASFGDIQKRQHLGKTEVEGyLVNYLELKKRQHPGRRSLWDQSTDISssqLTYLNELSKRQHPGRRYLMYKHQ 175
Cdd:pfam05438  89 GRREEEEEESYGDIQKRQHPGKREDEA-WDSYLELQKRQHPGRRSLLDQFSDNP---LGYLSELSKRQHPGRRYLMSKRQ 164

                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|....*.
gi 2024351123 176 HPSKRGWND---ELDLSD-QNWEKHQQFGNRDRDSDSPDYTGPCDLQQSAICNKDS 227
Cdd:pfam05438 165 HPGKRSWEDedeELDEEDlLELEKRQHPGKRFWDNSSPDLGSPCDVLDPASCSKTS 220
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH